The Challenge of Change - Managing Excipients Control
Colorcon
06-Feb-2012 - in-PharmaTechnologist presents its round-up of the latest appointments in the pharmaceutical industry, including news from Prosonix, Savient and Dendreon.
02-Feb-2012 - AstraZeneca will cut 1,350 operations jobs in the next few years as part of wide ranging restructuring move.
31-Jan-2012 - in-PharmaTechnologist presents its weekly round-up of the latest changes on the pharmaceutical career ladder, including news from Sirona, Hospira, and Biogen Idec.
27-Jan-2012 - Danone and Mead Johnson may make a joint bid for the €8bn infant nutrition-dominated Pfizer nutrition business that is up for sale, according to press reports.
26-Jan-2012 - Simplification of French tax laws would incentivise Pharmas to manufacture drugs in the country according to a government advisory body.
24-Jan-2012 - in-PharmaTechnololist presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Prosonix, GENO, and BioCryst.
18-Jan-2012 - Takeda has announced it will cut 2,800 jobs by 2015 as part of its integration of Nycomed.
17-Jan-2012 - in-PharmaTechnologist presents its weekly round-up of the latest career moves within the pharmaceutical industry, including news from Algeta, Pall and Octapharma.
17-Jan-2012 - Pharma giant GlaxoSmithKline (GSK) has moved its offices in charge of the Middle East and North African (MENA) market to Istanbul, Turkey.
16-Jan-2012 - Swiss drug major Novartis has announced plans to cut US jobs and predicts a challenging couple of years for its pharma division.
11-Jan-2012 - Sanofi announced it will cut $170m of its operational costs this year as it plans to ramp-up acquisitions spending to $2.6bn.
11-Jan-2012 - in-PharmaTechnologist presents its weekly round-up of the latest new faces at pharmas and biotechs, including news from Dicerna, Auxilium and Essentialis.
10-Jan-2012 - Xoma will further reduce its manufacturing capacity with plans to cut a third of its workforce.
09-Jan-2012 - Further analysis is needed to assess the risk posed by low level pharmaceutical contamination of water supplies says the winner of Recipharm’s 2011 environmental award.
04-Jan-2012 - GSK CEO Andrew Witty has been knighted in the Queen's New Year Honours list in recognition of his services to the UK economy and pharmaceutical industry.
04-Jan-2012 - The FDA should encourage industry to submit draft guidance to speed regulatory development, an agency working group found.
03-Jan-2012 - in-PharmaTechnologist presents its first weekly round-up of the new appointments in the industry of 2012, including news from Teva, Forma Therapeutics and Celgene.
23-Dec-2011 - In-Pharmatechnologist.com would like to wish all our readers a happy holiday
22-Dec-2011 - Amgen has partnered with non-branded drugmaker Watson to develop biosimilar cancer drugs in a deal that goes some way towards protecting its own portfolio from generic competition.
20-Dec-2011 - DSM Biologics will work with the Australian Institute for Bioengineering and Nanotechnology (AIBN) on the commercialisation of development-stage biologics projects.
19-Dec-2011 - in-PharmaTechnologist presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Vertex, Pfizer and Prolong.
13-Dec-2011 - Hospira says Chairman Christopher Begley’s impending retirement is unrelated to quality problems at manufacturing plant or recent investor criticism.
12-Dec-2011 - UK drug maker AstraZeneca has bought Chinese non-branded drugmaker Guangdong BeiKang Pharma.
12-Dec-2011 - Outsourcing-Pharma presents its weekly round-up of the latest movers and shakers in the pharmaceutical industry, including news from Inviragen, Auxilium, and Icon Biosciences.
07-Dec-2011 - US drug industry group PhRMA has backed FDA plans to discuss fees for biosimilars with pharmaceutical manufacturers.